Loading...
5 results
Search Results
Now showing 1 - 5 of 5
- Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in PracticePublication . Lourenço, Olga; Bosnic-Anticevich, Sinthia; Costa, Elísio; Fonseca, Joao A; Menditto, Enrica; Cvetkovski, Biljana; Kritikos, Vicky; Tan, Rachel; Bedbrook, Anna; Scheire, Sophie; Bachert, Claus; Białek, Sławomir; Briedis, Vitalis; Boussery, Koen; Canonica, G Walter; Haahtela, Tari; Kuna, Piotr; Novellino, Ettore; Samolinski, Boleslaw; Schünemann, Holger J; Wallace, Dana; Bousquet, JeanThe paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines.
- Identifying an effective mobile health application for the self-management of allergic rhinitis and asthma in AustraliaPublication . Tan, Rachel; Cvetkovski, Biljana; Koshelev, Alexey; O'Hehir, Robyn; Lourenço, Olga; Bousquet, Jean; Bosnic-Anticevich, SinthiaObjective: People with allergic rhinitis (AR) often self-manage in the community pharmacy setting without consulting health care professionals and trivialize their comorbidities such as asthma. A mobile health application (mHealth app) with a self-monitoring and medication adherence system can assist with the appropriate self-management of AR and asthma. This study aimed to identify an app effective for the self-management of AR and/or asthma. Methods: MHealth apps retrieved from the Australian Apple App Store and Android Google Play Store were included in this study if they were developed for self-management of AR and/or asthma; in English language; free of charge for the full version; and accessible to users of the mHealth app. The mHealth app quality was evaluated on three domains using a two-stage process. In Stage 1, the apps were ranked along Domain 1 (Accessibility in both app stores). In Stage 2, the apps with Stage 1, maximum score were ranked along Domain 2 (alignment with theoretical principles of the self-management of AR and/or asthma) and Domain 3 (usability of the mHealth app using Mobile App Rating Scale instrument). Results: Of the 418 apps retrieved, 31 were evaluated in Stage 1 and 16 in Stage 2. The MASK-air achieved the highest mean rank and covered all self-management principles except the doctor's appointment reminder and scored a total MARS mean score of 0.91/1. Conclusions:MASK-air is ranked most highly across the assessment domains for the self-management of both AR and coexisting asthma. This mHealth app covers the majority of the self-management principles and is highly engaging.
- Interventions Delivered in the Community Pharmacy to Manage Allergic RhinitisPublication . José, Jéssica; Cvetkovski, Biljana; Kritikos, Vicky; Tan, Rachel; Bosnic-Anticevich, Sinthia; Lourenço, OlgaPharmacists have a valuable role in the management of allergic rhinitis (AR) at the community pharmacy level. This role has been reported extensively in numerous papers. However, a systematic review of the available literature and a comprehensive analysis of the outcomes has not been published. This systematic review aimed to evaluate the impact of interventions developed by pharmacists on clinical AR outcomes. A thorough search was performed in three electronic databases, including studies published between January 2000 and June 2019. After the selection process, only three articles met the inclusion criteria and were further analysed. Despite the scarcity of the available studies, in all of them was clear that the pharmacist plays a pivotal role in the management of AR, significantly improving the patients' quality of life and symptom control. This systematic review also stresses the utmost importance to investigate and report practices and interventions developed by pharmacists using measurable outcomes.
- ARIA pharmacy 2018: Allergic rhinitis care pathways for community pharmacyPublication . Bosnic-Anticevich, Sinthia; Costa, Elísio; Menditto, Enrica; Lourenço, Olga; Novellino, Ettore; Bialek, Slawomir; Briedis, Vitalis; Buonaiuto, Roland; Chrystyn, Henry; Cvetkovski, Biljana; Di Capua, Stefania; Park, Hae-Sim; Phillips, Jim; Plavec, Davor; Stellato, Cristiana; Somekh, David; Sisul, Juan; To, Teresa; Todo-Bom, Ana; Tomazic, Peter Valentin; Toppila-Salmi, Sanna; Valero, Antonio; Popov, Todor A; Potter, Paul C; Prokopakis, Emmanuel P; Roller-Wirnsberger, Regina E; Rottem, Menachem; Ryan, Dermot; Samolinski, Boleslaw; Sanchez-Borges, Mario; Schunemann, Holger J; Sheikh, Aziz; Ventura, Maria Teresa; Valovirta, Erkka; Valiulis, Arunas; Wagenmann, Martin; Kritikos, Vicky; Bousquet, Jean; Zuberbier, Torsten; Mair, Alpana; Orlando, Valentina; Paulino, Ema; Salimäki, Johanna; Söderlund, Rojin; Wallace, Dana; Waserman, Susan; Wickman, Magnus; Yiallouros, Panayiotis; Yorgancioglu, Arzu; Yusuf, Osman; Zar, Heather J; Zernotti, Mario E; Zhang, Luo; Zidarn, Mihaela; Wroczynski, Piotr; Williams, Dennis M; Tan, Rachel; Agache, Ioana; Ansotegui, Ignacio J; Cruz, Alvaro A; Sousa, Jaime Correia de; Chavannes, Niels H; Czarlewski, Wienczyslawa; De Carlo, Giuseppe; Demoly, Pascal; Devillier, Philippe; Anto, Josep M; Bedbrook, Anna; Bachert, Claus; Bewick, Mike; Bindslev-Jensen, Carsten; Brozek, Jan L; Canonica, Giorgio Walter; Cardona, Victoria; Carr, Warner; Casale, Thomas; El-Gamal, Yehia; Gaga, Mina; Dykewicz, Mark S; Fonseca, João; Fokkens, Wytske J; Kuna, Piotr; Kowalski, Marek; Klimek, Ludger; Kvedarienė, Violeta; Linnemann, Désirée Larenas; Laune, Daniel; Le Thi Tuyet, Lan; Guzman, Maria Antonieta; Haahtela, Tari; Hellings, Peter; Illario, Maddalena; Ivancevich, Juan Carlos; Just, Jocelyne; Kaidashev, Igor; Khaitov, Musa; Khaltaev, Nikolai; Keil, Thomas; Maier, Dieter; Mahboub, Bassam; Lodrup Carlsen, Karin C; Malva, João; Manning, Patrick J; Okamoto, Yoshitaka; Ohta, Ken; O'Hehir, Robyn; Onorato, Gabrielle L; Palkonen, Susanna; Panzner, Petr; Papadopoulos, Nikolaos G.; Almeida, Mário Morais; Mösges, Ralph; Mullol, Joaquim; Münter, Lars; Murray, Ruth; Naclerio, Robert; Namazova-Baranova, Leyla; Nekam, Kristof; Nyembue, Tshipukane Dieudonné; Okubo, Kimihiro; Pfaar, Oliver; Pawankar, RubyPharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.
- Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?Publication . Bousquet, Jean; Ansotegui, Ignacio J; Anto, Josep M.; Arnavielhe, Sylvie; Bachert, Claus; Basagaña, Xavier; Bédard, Annabelle; Bedbrook, Anna; Bonini, Matteo; Bosnic-Anticevich, Sinthia; Braido, Fulvio; Cardona, Vicky; Czarlewski, Wienczyslawa; Cruz, Alvaro A; Demoly, Pascal; De Vries, Govert; Dramburg, Stephanie; Mathieu-Dupas, Eve; Erhola, Marina; Fokkens, Wytske J; Fonseca, Joao A; Haahtela, Tari; Hellings, Peter; Illario, Maddalena; Ivancevich, Juan Carlos; Jormanainen, Vesa; Klimek, Ludger; Kuna, Piotr; Kvedarienė, Violeta; Laune, Daniel; Linnemann, Désirée Larenas; Lourenço, Olga; Onorato, Gabrielle L; Matricardi, Paolo M; Melén, Erik; Mullol, Joaquim; Papadopoulos, Nikos G; Pfaar, Oliver; Pham-Thi, Nhân; Sheikh, Aziz; Tan, Rachel; To, Teresa; Tomazic, Peter Valentin; Toppila-Salmi, Sanna; Tripodi, Salvadore; Wallace, Dana; Valiulis, Arunas; Van Eerd, Michiel; Ventura, Maria Teresa; Yorgancioglu, Arzu; Zuberbier, TorstenSmart devices and Internet-based applications (apps) are largely used in allergic rhinitis and may help to address some unmet needs. However, these new tools need to first of all be tested for privacy rules, acceptability, usability, and cost-effectiveness. Second, they should be evaluated in the frame of the digital transformation of health, their impact on health care delivery, and health outcomes. This review (1) summarizes some existing mobile health apps for allergic rhinitis and reviews those in which testing has been published, (2) discusses apps that include risk factors of allergic rhinitis, (3) examines the impact of mobile health apps in phenotype discovery, (4) provides real-world evidence for care pathways, and finally (5) discusses mobile health tools enabling the digital transformation of health and care, empowering citizens, and building a healthier society.